Penumbra, headquartered in Alameda, California, designs and manufactures innovative medical devices for challenging conditions, employing 4,200 staff since its IPO on September 18, 2015. The company focuses on products for specialist physicians to improve clinical outcomes.
Penumbra (PEN) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Penumbra's actual EPS was $0.83, beating the estimate of $0.67 per share, resulting in a 23.86% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
